Skip to main content
. 2022 Mar 23;14(4):694. doi: 10.3390/pharmaceutics14040694

Figure 5.

Figure 5

Summary figure. Both CYP3A and OATP1B1 contribute to the pharmacokinetics of venetoclax and are inhibited by antifungal drugs. Solid lines represent knowledge gaps clarified by our experiments.